- Home
- RRBI vs AUTL Comparison
RRBI vs AUTL Comparison
Compare RRBI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- AUTL
- Stock Information
- Founded
- RRBI 1998
- AUTL 2014
- Country
- RRBI United States
- AUTL United Kingdom
- Employees
- RRBI N/A
- AUTL N/A
- Industry
- RRBI Hotels/Resorts
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRBI Consumer Discretionary
- AUTL Health Care
- Exchange
- RRBI Nasdaq
- AUTL Nasdaq
- Market Cap
- RRBI 333.5M
- AUTL 360.6M
- IPO Year
- RRBI 2019
- AUTL 2018
- Fundamental
- Price
- RRBI $49.91
- AUTL $1.43
- Analyst Decision
- RRBI
- AUTL Strong Buy
- Analyst Count
- RRBI 0
- AUTL 5
- Target Price
- RRBI N/A
- AUTL $9.32
- AVG Volume (30 Days)
- RRBI 7.7K
- AUTL 1.8M
- Earning Date
- RRBI 04-28-2025
- AUTL 05-13-2025
- Dividend Yield
- RRBI 0.95%
- AUTL N/A
- EPS Growth
- RRBI 1.85
- AUTL N/A
- EPS
- RRBI 4.95
- AUTL N/A
- Revenue
- RRBI $108,680,000.00
- AUTL $10,120,000.00
- Revenue This Year
- RRBI N/A
- AUTL $277.74
- Revenue Next Year
- RRBI $5.59
- AUTL $221.89
- P/E Ratio
- RRBI $10.08
- AUTL N/A
- Revenue Growth
- RRBI 1.74
- AUTL 496.00
- 52 Week Low
- RRBI $42.78
- AUTL $1.11
- 52 Week High
- RRBI $62.13
- AUTL $5.25
- Technical
- Relative Strength Index (RSI)
- RRBI 45.34
- AUTL 45.37
- Support Level
- RRBI $47.75
- AUTL $1.32
- Resistance Level
- RRBI $49.58
- AUTL $1.45
- Average True Range (ATR)
- RRBI 1.78
- AUTL 0.16
- MACD
- RRBI 0.08
- AUTL 0.02
- Stochastic Oscillator
- RRBI 49.18
- AUTL 61.90
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.